{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:42:46Z","timestamp":1792640566635,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL 123346"],"award-info":[{"award-number":["HL 123346"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 HL 108551"],"award-info":[{"award-number":["RO1 HL 108551"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.metabol.2016.01.007","type":"journal-article","created":{"date-parts":[[2016,1,17]],"date-time":"2016-01-17T00:22:15Z","timestamp":1452990135000},"page":"623-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Kinase-SUMO networks in diabetes-mediated cardiovascular disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Eugene","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2016.01.007_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.108.846519","article-title":"Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the framingham heart study","volume":"120","author":"Preis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","article-title":"Diabetes and cardiovascular risk factors: The framingham study","volume":"59","author":"Kannel","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (ukpds 33). Uk prospective diabetes study (ukpds) group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2016.01.007_bb0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2016.01.007_bb0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0735-1097(01)01682-5","article-title":"Aha\/acc guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the american heart association and the american college of cardiology","volume":"38","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0030","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.01.007_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.01.007_bb0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the accord randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2016.01.007_bb0045","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2016.01.007_bb0050","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1042\/BST20140113","article-title":"Endothelial cell oxidative stress in diabetes: A key driver of cardiovascular complications?","volume":"42","author":"Shaw","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.metabol.2016.01.007_bb0055","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part i","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2016.01.007_bb0060","doi-asserted-by":"crossref","first-page":"160692","DOI":"10.1155\/2014\/160692","article-title":"The role of ubiquitination and sumoylation in diabetic nephropathy","volume":"2014","author":"Gao","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.metabol.2016.01.007_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2005.03.012","article-title":"Sumo: A history of modification","volume":"18","author":"Hay","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2016.01.007_bb0070","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1042\/BST0351414","article-title":"Signalling pathways and the regulation of sumo modification","volume":"35","author":"Guo","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.metabol.2016.01.007_bb0075","first-page":"947","article-title":"Concepts in sumoylation: A decade on. Nature reviews","volume":"8","author":"Geiss-Friedlander","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0080","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2010-08-302281","article-title":"Mk2 sumoylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting mk2 kinase and hsp27 phosphorylation","volume":"117","author":"Chang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2016.01.007_bb0085","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1074\/jbc.R800050200","article-title":"Sumoylation and de-sumoylation: Wrestling with life's processes","volume":"284","author":"Yeh","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.01.007_bb0090","first-page":"755","article-title":"Function and regulation of sumo proteases. Nature reviews","volume":"13","author":"Hickey","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0095","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.CIR.94.6.1276","article-title":"Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus","volume":"94","author":"Makimattila","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0735-1097(96)82380-1","article-title":"Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels","volume":"28","author":"Clarkson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/ATVBAHA.110.217901","article-title":"Protein kinase c upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed calpain","volume":"31","author":"Smolock","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0110","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2016.01.007_bb0115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2016.01.007_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI10373","article-title":"Nf-kappab: Pivotal mediator or innocent bystander in atherogenesis?","volume":"107","author":"Collins","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.01.007_bb0125","doi-asserted-by":"crossref","first-page":"H317","DOI":"10.1152\/ajpheart.00182.2013","article-title":"New paradigms in inflammatory signaling in vascular endothelial cells","volume":"306","author":"Xiao","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/embor.2008.122","article-title":"Sumo1 modification of nf-kappab2\/p100 is essential for stimuli-induced p100 phosphorylation and processing","volume":"9","author":"Vatsyayan","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.metabol.2016.01.007_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1097-2765(00)80133-1","article-title":"Sumo-1 modification of ikappabalpha inhibits nf-kappab activation","volume":"2","author":"Desterro","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2016.01.007_bb0140","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/MCB.00409-10","article-title":"Mechanism of hypoxia-induced nf-kappab","volume":"30","author":"Culver","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2013.07.065","article-title":"High glucose induces activation of nf-kappab inflammatory signaling through ikappabalpha sumoylation in rat mesangial cells","volume":"438","author":"Huang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2016.01.007_bb0150","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.2337\/diabetes.53.11.2910","article-title":"Activation of nuclear factor-kappab by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase","volume":"53","author":"Ramana","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.01.007_bb0155","doi-asserted-by":"crossref","first-page":"C182","DOI":"10.1152\/ajpcell.00575.2007","article-title":"High glucose-induced ikk-hsp-90 interaction contributes to endothelial dysfunction","volume":"296","author":"Mohan","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0160","doi-asserted-by":"crossref","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","article-title":"The ikk complex, a central regulator of nf-kappab activation","volume":"2","author":"Israel","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/cr.2010.179","article-title":"Nuclear initiated nf-kappab signaling: Nemo and atm take center stage","volume":"21","author":"Miyamoto","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0170","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCRESAHA.111.300179","article-title":"De-sumoylation enzyme of sentrin\/sumo-specific protease 2 regulates disturbed flow-induced sumoylation of erk5 and p53 that leads to endothelial dysfunction and atherosclerosis","volume":"112","author":"Heo","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0175","doi-asserted-by":"crossref","first-page":"e1003480","DOI":"10.1371\/journal.ppat.1003480","article-title":"Negative regulation of tlr inflammatory signaling by the sumo-deconjugating enzyme senp6","volume":"9","author":"Liu","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.metabol.2016.01.007_bb0180","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase c isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021626","article-title":"Regulation of the abc kinases by phosphorylation: Protein kinase c as a paradigm","volume":"370","author":"Newton","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2016.01.007_bb0190","doi-asserted-by":"crossref","first-page":"11233","DOI":"10.1073\/pnas.94.21.11233","article-title":"Activation of protein kinase c by tyrosine phosphorylation in response to h2o2","volume":"94","author":"Konishi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2016.01.007_bb0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCULATIONAHA.112.127514","article-title":"Protein kinase c-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus","volume":"127","author":"Tabit","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0200","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1111\/febs.12285","article-title":"The tail wagging the dog--regulation of lipid metabolism by protein kinase c","volume":"280","author":"Schmitz-Peiffer","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.metabol.2016.01.007_bb0205","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1582-4934.2008.00629.x","article-title":"Enforced expression of protein kinase c in skeletal muscle causes physical inactivity, fatty liver and insulin resistance in the brain","volume":"14","author":"Hennige","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2016.01.007_bb0210","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/ATVBAHA.111.229260","article-title":"Oxidized low-density lipoprotein activates p66shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase c-beta, and c-jun n-terminal kinase kinase in human endothelial cells","volume":"31","author":"Shi","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1194\/jlr.M019687","article-title":"Protein kinase cbeta deficiency attenuates obesity syndrome of ob\/ob mice by promoting white adipose tissue remodeling","volume":"53","author":"Huang","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0220","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/diabetes.49.7.1239","article-title":"Induction of endothelin-1 expression by glucose: An effect of protein kinase c activation","volume":"49","author":"Park","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2016.01.007_bb0225","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/MCB.00506-13","article-title":"Serine phosphorylation sites on irs2 activated by angiotensin ii and protein kinase c to induce selective insulin resistance in endothelial cells","volume":"33","author":"Park","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0230","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1096\/fj.08-120345","article-title":"Mice deficient in pkcbeta and apolipoprotein e display decreased atherosclerosis","volume":"23","author":"Harja","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2016.01.007_bb0235","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1161\/ATVBAHA.112.301113","article-title":"Pkcbeta promotes vascular inflammation and acceleration of atherosclerosis in diabetic apoe null mice","volume":"33","author":"Kong","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0240","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2010-0286","article-title":"Inhibition of protein kinase cbeta does not improve endothelial function in type 2 diabetes","volume":"95","author":"Beckman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2016.01.007_bb0245","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/ncomms5980","article-title":"Kainate receptor activation induces glycine receptor endocytosis through pkc desumoylation","volume":"5","author":"Sun","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2016.01.007_bb0250","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1161\/ATVBAHA.114.303428","article-title":"Novel mechanisms of endothelial mechanotransduction","volume":"34","author":"Abe","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0255","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1084\/jem.20060245","article-title":"Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis","volume":"203","author":"Jongstra-Bilen","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2016.01.007_bb0260","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1253\/circj.CJ-11-1124","article-title":"Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction","volume":"75","author":"Heo","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.metabol.2016.01.007_bb0265","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1128\/MCB.20.22.8382-8389.2000","article-title":"Erk5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain","volume":"20","author":"Kasler","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0270","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1128\/MCB.24.19.8691-8704.2004","volume":"24","author":"Akaike","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0275","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/ars.2008.2280","article-title":"Ppars and the cardiovascular system","volume":"11","author":"Hamblin","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2016.01.007_bb0280","doi-asserted-by":"crossref","first-page":"34176","DOI":"10.1074\/jbc.M203436200","article-title":"Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.01.007_bb0285","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1087344","article-title":"Transcriptional repression of atherogenic inflammation: Modulation by ppardelta","volume":"302","author":"Lee","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.metabol.2016.01.007_bb0290","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","article-title":"Anti-inflammatory actions of ppar ligands: New insights on cellular and molecular mechanisms","volume":"28","author":"Straus","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0295","doi-asserted-by":"crossref","first-page":"32164","DOI":"10.1074\/jbc.M602369200","article-title":"Erk5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor delta (ppardelta) stimulation","volume":"281","author":"Woo","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.01.007_bb0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1172\/JCI24787","article-title":"Integration of flow-dependent endothelial phenotypes by kruppel-like factor 2","volume":"116","author":"Parmar","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.01.007_bb0305","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.20031132","article-title":"Klf2 is a novel transcriptional regulator of endothelial proinflammatory activation","volume":"199","author":"SenBanerjee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2016.01.007_bb0310","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1161\/ATVBAHA.110.211474","article-title":"Kruppel-like factor 2 regulates endothelial barrier function","volume":"30","author":"Lin","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0315","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.104.525774","article-title":"Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells","volume":"112","author":"Sen-Banerjee","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0320","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbrc.2009.12.002","article-title":"Defining the regulation of klf4 expression and its downstream transcriptional targets in vascular endothelial cells","volume":"391","author":"Villarreal","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2016.01.007_bb0325","doi-asserted-by":"crossref","first-page":"26199","DOI":"10.1074\/jbc.M110.103127","article-title":"Erk5 activation elicits a vasoprotective endothelial phenotype via induction of kruppel-like factor 4 (klf4)","volume":"285","author":"Ohnesorge","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.01.007_bb0330","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI200419890","article-title":"Targeted deletion of bmk1\/erk5 in adult mice perturbs vascular integrity and leads to endothelial failure","volume":"113","author":"Hayashi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.01.007_bb0335","doi-asserted-by":"crossref","first-page":"43344","DOI":"10.1074\/jbc.M207573200","article-title":"Erk5 mapk regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression","volume":"277","author":"Sohn","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2016.01.007_bb0340","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCULATIONAHA.112.116988","article-title":"A crucial role for p90rsk-mediated reduction of erk5 transcriptional activity in endothelial dysfunction and atherosclerosis","volume":"127","author":"Le","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0345","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCRESAHA.107.156877","article-title":"Extracellular signal-regulated kinase 5 sumoylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells","volume":"102","author":"Woo","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0350","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.cdd.4402303","article-title":"Senp1 mediates tnf-induced desumoylation and cytoplasmic translocation of hipk1 to enhance ask1-dependent apoptosis","volume":"15","author":"Li","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.metabol.2016.01.007_bb0355","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2007.08.045","article-title":"Sumo-specific protease 1 is essential for stabilization of hif1alpha during hypoxia","volume":"131","author":"Cheng","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2016.01.007_bb0360","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.atherosclerosis.2009.02.031","article-title":"Effect of a peroxisome proliferator-activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in rats","volume":"206","author":"Lim","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2016.01.007_bb0365","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2010-02-269134","article-title":"Pkczeta decreases enos protein stability via inhibitory phosphorylation of erk5","volume":"116","author":"Nigro","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2016.01.007_bb0370","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0303-7207(99)00061-1","article-title":"Role and regulation of 90 kda ribosomal s6 kinase (rsk) in signal transduction","volume":"151","author":"Frodin","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/JCI76453","article-title":"Disturbed flow-activated p90rsk kinase accelerates atherosclerosis by inhibiting senp2 function","author":"Heo","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.01.007_bb0380","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/01.CIR.101.24.2854","article-title":"Left ventricular hypertrophy in ascending aortic stenosis mice: Anoikis and the progression to early failure","volume":"101","author":"Ding","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0385","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.0506489102","article-title":"A positive feedback loop of phosphodiesterase 3 (pde3) and inducible camp early repressor (icer) leads to cardiomyocyte apoptosis","volume":"102","author":"Ding","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2016.01.007_bb0390","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/CIRCRESAHA.107.168138","article-title":"Effects of mek5\/erk5 association on small ubiquitin-related modification of erk5: Implications for diabetic ventricular dysfunction after myocardial infarction","volume":"102","author":"Shishido","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0395","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCRESAHA.109.209320","article-title":"Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart","volume":"106","author":"Kimura","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0400","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.RES.0000259045.49371.9c","article-title":"Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3a\/inducible camp early repressor feedback loop","volume":"100","author":"Yan","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0405","doi-asserted-by":"crossref","first-page":"H2836","DOI":"10.1152\/ajpheart.01122.2004","article-title":"Chip, a cochaperone\/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice","volume":"288","author":"Zhang","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0410","first-page":"4917","article-title":"Novel role of c terminus of hsc70-interacting protein (chip) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating erk5-mediated degradation of inducible camp early repressor","volume":"24","author":"Woo","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2016.01.007_bb0415","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI118054","article-title":"Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes","volume":"96","author":"Yamazaki","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2016.01.007_bb0420","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.RES.78.1.82","article-title":"Hypoxia and hypoxia\/reoxygenation activate raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases, and s6 kinase in cultured rat cardiac myocytes","volume":"78","author":"Seko","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0425","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.RES.85.12.1164","article-title":"Differential regulation of p90 ribosomal s6 kinase and big mitogen-activated protein kinase 1 by ischemia\/reperfusion and oxidative stress in perfused guinea pig hearts","volume":"85","author":"Takeishi","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0430","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1006\/jmcc.2001.1427","article-title":"Src and multiple map kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: Comparison with acute mechanical stretch","volume":"33","author":"Takeishi","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2016.01.007_bb0435","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0008-6363(01)00438-2","article-title":"Activation of mitogen-activated protein kinases and p90 ribosomal s6 kinase in failing human hearts with dilated cardiomyopathy","volume":"53","author":"Takeishi","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2016.01.007_bb0440","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.105.578278","article-title":"Role of p90 ribosomal s6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium","volume":"113","author":"Itoh","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2016.01.007_bb0445","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/CIRCRESAHA.111.254730","article-title":"P90rsk targets the erk5-chip ubiquitin e3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction","volume":"110","author":"Le","year":"2012","journal-title":"Circ Res"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:10:22Z","timestamp":1758427822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0026049516000147"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2016.01.007","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinase-SUMO networks in diabetes-mediated cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}